Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 1 feed behind: Insider filings, 2 days · Every feed →

All 10Congress 0Executive branch 0Insiders 10
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

GRCE · Insiders · $15K+ · 10 trades

Trades
10
Buys 10 · Sells 0
People
2
Stocks
1
Disclosed value
$551K
range midpoints · Congress & executive
Filed late
1
  1. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$21.7Kdisclosed Oct 16 · filed 2 days after the trade
  2. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$68.8Kdisclosed Oct 16 · filed the same day
  3. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$45.7Kdisclosed Oct 16 · filed 1 day after the trade
  4. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$41.4Kdisclosed Oct 5 · filed 3 days after the trade
  5. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$79Kdisclosed Oct 5 · filed 4 days after the trade
  6. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$16.4Kdisclosed Oct 1 · filed 2 days after the trade
  7. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$20.5Kdisclosed Sep 23 · filed 2 days after the trade
  8. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$19.7Kdisclosed Sep 10 · filed 2 days after the trade
  9. ▲ BUYPrashant Kohli Chief Executive OfficerGRCE Grace Therapeutics, Inc.$214Kdisclosed Sep 10 · filed 1 day after the trade
  10. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$24.2Kdisclosed Aug 19 · filed 5 days after the trade · late